MicroRNA-targeted therapeutics for lung cancer treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

MicroRNA-targeted therapeutics for lung cancer treatment

Published:2016-11-28 Issue:2 Volume:12 Page:141-157
ISSN:1746-0441
Container-title:Expert Opinion on Drug Discovery
language:en
Short-container-title:Expert Opinion on Drug Discovery

Author:

Xue Jing¹²,Yang Jiali¹,Luo Meihui¹,Cho William C.³,Liu Xiaoming¹²⁴

Affiliation:

1. Center of Laboratory Medicine, General Hospital of Ningxia Medical University, Yinchuan, China

2. College of Life Science, Ningxia University, Yinchuan, China

3. Department of Clinical Oncology, Queen Elizabeth Hospital, Kowloon, Hong Kong

4. Human Stem Cell Institute, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China

Funder

National Natural Science Foundation of China

Publisher

Informa UK Limited

Subject

Drug Discovery

Link

https://www.tandfonline.com/doi/pdf/10.1080/17460441.2017.1263298

Reference164 articles.

1. Molecularly Targeted Therapies in Non–Small-Cell Lung Cancer Annual Update 2014

2. Emerging Roles of MicroRNAs in EGFR-Targeted Therapies for Lung Cancer

3. Wnt signaling as potential therapeutic target in lung cancer

4. Intracranial Efficacy of Crizotinib Versus Chemotherapy in Patients With Advanced ALK-Positive Non–Small-Cell Lung Cancer: Results From PROFILE 1014

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circular RNAs and the JAK/STAT pathway: New frontiers in cancer therapeutics;Pathology - Research and Practice;2024-08

2. Exosome prospects in the diagnosis and treatment of non-alcoholic fatty liver disease;Frontiers in Medicine;2024-07-31

3. Novel RNA molecular bioengineering technology efficiently produces functional miRNA agents;RNA;2024-03-01

4. MicroRNA‐140‐3p inhibits proliferation and promotes apoptosis in non‐small cell lung cancer by targeting MDIG;Environmental Toxicology;2023-11-27

5. UBE3A and MCM6 synergistically regulate the proliferation and migration of lung adenocarcinoma cells;FEBS Open Bio;2023-07-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3